5T1L
Cetuximab Fab in complex with CQA(Ph)2DLSTRRLKC peptide
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | ROTATING ANODE |
Source details | RIGAKU MICROMAX-007 HF |
Temperature [K] | 100 |
Detector technology | IMAGE PLATE |
Collection date | 2011-08-19 |
Detector | RIGAKU RAXIS IV++ |
Wavelength(s) | 1.5418 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 64.050, 82.970, 211.960 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 34.360 - 2.480 |
R-factor | 0.16 |
Rwork | 0.158 |
R-free | 0.20400 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4gw1 |
RMSD bond length | 0.008 |
RMSD bond angle | 1.178 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | MOLREP |
Refinement software | PHENIX (1.8.1_1168) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 34.400 | 2.540 |
High resolution limit [Å] | 2.480 | 2.480 |
Rmerge | 0.059 | 0.280 |
Number of reflections | 40655 | |
<I/σ(I)> | 24.9 | 5 |
Completeness [%] | 99.4 | 92.6 |
Redundancy | 6.2 | 4.3 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 5.5 | 293 | 0.1 M CITRIC ACID, 0.1 M SODIUM HYDROGEN PHOSPHATE, 0.4 M POTASSIUM HYDROGEN PHOSPHATE, 1.6 M SODIUM DIHYDROGEN PHOSPHATE, pH 5.5 |